Lite Strategy | Sustainability Performance
Develops and commercializes oncology therapies, focusing on treatments for blood cancers and solid tumors. Emphasizes innovation and improving patient outcomes in cancer care.
2000
United States
11 - 50 employees
Biotechnology
$25M - 100M in revenue
$10M - 25M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4790
Overallⓘ#952
in United Statesⓘ#103
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
Powered by illuminem
